title: Teratogenesis in repeated pregnancies in antiepileptic drug-treated women.
abstract: OBJECTIVE
  Considerable information is now available concerning the risk of teratogenesis in the individual pregnancy exposed to antiepileptic drugs (AEDs). However, there is comparatively little information available concerning the risk in the subsequent pregnancies of women who continue to take the AED associated with a fetal malformation in a previous pregnancy. This article addresses this matter.
  
  
  METHODS
  Analysis of data concerning fetal abnormalities in 1,243 women who had 2,637 pregnancies between mid-1999 and 2010 recorded in the Australian Register of Antiepileptic Drugs in Pregnancy. Of the 2,637 pregnancies, 1,114 had been completed before initial enrolment in the Register.
  
  
  RESULTS
  Women taking any AED who had given birth to a malformed baby in their first enrolled pregnancy and who continue taking the same drug were at increased risk of having a malformed offspring in their next pregnancy (35.7% vs. 3.1%; odds ratio [OR] 17.6; 95% confidence interval [95% CI] 4.5-68.7). Among these women, those taking valproate (VPA) were more likely to have malformed fetuses in their next pregnancies than those who had taken VPA without fetal abnormalities (57.2% vs. 7.0%, OR 17.8; 95% CI 2.7, 119.1). There were similar although not statistically significant trends in those who had taken AEDs other than VPA. Similar, although again not statistically significant, trends were found, when considering the pairings of the most recent preenrollment pregnancy and the following one. If a woman had two or more pregnancies that resulted in AED-associated fetal malformation, the types of malformation were often different.
  
  
  CONCLUSIONS
  Women whose last pregnancy resulted in a fetal malformation have a substantially increased risk of having further malformed fetuses if they become pregnant again while taking the same AED, particularly VPA. This suggests that maternal factors, perhaps genomic, predispose to at least VPA-associated malformations. This knowledge, together with information about the outcome of any previous pregnancy, should help in advising women with AED-treated epilepsy who plan further pregnancies.
authors.affiliation: Departments of Medicine and Neurology, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia. vajda@netspace.net.au
authors.forename: Frank J E
authors.initials: FJ
authors.lastname: Vajda
authors.forename: Terence J
authors.initials: TJ
authors.lastname: O'Brien
authors.forename: Cecilie M
authors.initials: CM
authors.lastname: Lander
authors.forename: Janet
authors.initials: J
authors.lastname: Graham
authors.forename: Annie
authors.initials: A
authors.lastname: Roten
authors.forename: Mervyn J
authors.initials: MJ
authors.lastname: Eadie
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000453:epidemiology / Q000209:etiology*; D000927:Anticonvulsants / Q000627:therapeutic use / Q000633:toxicity*; D001315:Australia / Q000453:epidemiology; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D010298:Parity; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D012008:Recurrence; D012042:Registries; D012189:Retrospective Studies; D012307:Risk Factors; D014635:Valproic Acid / Q000627:therapeutic use / Q000633:toxicity
chemical_list: D000927:Anticonvulsants; D014635:Valproic Acid